poisar

Stock

Pulmatrix, Inc. PULM

$1.56+0.00%

Overview

PULM market data

Price History

PULM price chart · 3M
O
1.56
H
1.56
L
1.56
C
1.56
Vol
0.000000
Source
US equities market feed
Observed
Aug 26, 2026, 12:00 AM
Cadence
Five-minute page cache; daily and stored hourly bars
Status
fresh

Key Stats & Performance

Open
$1.56
Previous Close
$1.56
Day High
$1.56
Day Low
$1.56
52 Week High
$1.85
52 Week Low
$1.25
7 Day Return
+4.00%
30 Day Return
-9.83%
90 Day Return
+15.56%
1 Year Return
+13.04%
Daily Notional Volume
$0
Latest daily bar volume multiplied by its closing price.

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$1.41
Diluted earnings per share over the trailing twelve months.
Beta
2.01
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
-122.5%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$1.16 – $5.50
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $5.5M · P/B 2.14 · P/S 0.71.

Company News

4 captured
Pulmatrix Q2 EPS $(0.29) Up From $(0.42) YoYBenzinga · Aug 13, 2026, 12:52 PM
8-K filing — Pulmatrix, Inc. (PULM)SEC EDGAR · Aug 13, 2026, 12:15 PM
Halper Sadeh LLC is Investigating Whether SLP, HUN, OLN, PULM are Obtaining Fair Deals for their ShareholdersGlobenewswire Inc · Jul 10, 2026, 9:15 PM
Eos SENOLYTIX Presents Best-in-Class Preclinical Body Composition Data Highlighting Unique Muscle Mass Gains with MitoXcel™ Geropeptide PTC-2105 at the Sachs 2nd Annual Obesity & Cardiometabolic Innovation ForumGlobenewswire Inc · Jun 5, 2026, 12:15 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock